ABT Abbott

Abbott Receives FDA Approval for Libre Duo Dual Glucose-Ketone Sensor

Abbott announced FDA approval of Libre Duo, the first dual glucose-ketone biowearable sensor. The device provides real-time visibility into both glucose and ketone levels to help detect rising ketones that can lead to diabetic ketoacidosis.

Abbott receives FDA approval for CardioMEMS HF System with CardioGuide HF App

The FDA approved new capabilities for Abbott's CardioMEMS HF System allowing U.S. patients to view their own pulmonary artery pressure readings and receive personalized medication updates via the CardioGuide HF App for the first time. This enables earlier intervention as rising PAP signals worsening heart failure before symptoms appear.

Abbott partners with Berry Street to combine Lingo CGM with insurance-covered dietitian coaching

Abbott and Berry Street announced an exclusive partnership integrating Lingo continuous glucose monitor insights with Berry Street's registered dietitian nutrition therapy. The collaboration provides personalized nutrition recommendations based on glucose trends for consumers seeking better metabolic health, including those with prediabetes.